Michelle Petri

Professor

1985 …2018
If you made any changes in Pure these will be visible here soon.

Fingerprint Fingerprint is based on mining the text of the experts' scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 5 Similar Profiles
Systemic Lupus Erythematosus Medicine & Life Sciences
Lupus Nephritis Medicine & Life Sciences
Antiphospholipid Antibodies Medicine & Life Sciences
Antiphospholipid Syndrome Medicine & Life Sciences
Pregnancy Medicine & Life Sciences
Kidney Medicine & Life Sciences
African Americans Medicine & Life Sciences
Autoantibodies Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1985 2018

A Prospective International Study on Adherence to Treatment in 305 Patients With Flaring SLE: Assessment by Drug Levels and Self-Administered Questionnaires

Costedoat-Chalumeau, N. , Houssiau, F. , Izmirly, P. , Le Guern, V. , Navarra, S. , Jolly, M. , Ruiz-Irastorza, G. , Baron, G. , Hachulla, E. , Agmon-Levin, N. , Shoenfeld, Y. , Dall'Ara, F. , Buyon, J. , Deligny, C. , Cervera, R. , Lazaro, E. , Bezanahary, H. , Leroux, G. , Morel, N. , Viallard, J. F. & 11 others Pineau, C., Galicier, L., Van Vollenhoven, R., Tincani, A., Nguyen, H., Gondran, G., Zahr, N., Pouchot, J., Piette, J. C., Petri, M. & Isenberg, D. Jun 1 2018 In : Clinical Pharmacology and Therapeutics. 103, 6, p. 1074-1082 9 p.

Research output: Contribution to journalArticle

Prospective Studies
Hydroxychloroquine
Pharmaceutical Preparations
Tablets
Physicians

Autoimmune reactivity to malondialdehyde adducts in systemic lupus erythematosus is associated with disease activity and nephritis

Hardt, U., Larsson, A., Gunnarsson, I., Clancy, R. M., Petri, M., Buyon, J. P., Silverman, G. J., Svenungsson, E. & Grönwall, C. Feb 26 2018 In : Arthritis Research and Therapy. 20, 1, 36

Research output: Contribution to journalArticle

Nephritis
Malondialdehyde
Systemic Lupus Erythematosus
Complement C1q
Inflammation

Breast cancer in systemic lupus erythematosus (SLE): receptor status and treatment

Chan, K., Clarke, A. E., Ramsey-Goldman, R., Foulkes, W., Tessier Cloutier, B., Urowitz, M. B., Gladman, D., Nived, O., Romero-Diaz, J., Petri, M., Ginzler, E., Fortin, P. R., Bae, S. C., Wallace, D. J., Yelin, E. H. & Bernatsky, S. Jan 1 2018 In : Lupus. 27, 1, p. 120-123 4 p.

Research output: Contribution to journalArticle

Systemic Lupus Erythematosus
Progesterone
Estrogens
Estrogen Receptors
Breast Neoplasms

Clinical trial parameters that influence outcomes in lupus trials that use the systemic lupus erythematosus responder index

Kalunian, K. C., Urowitz, M. B., Isenberg, D., Merrill, J. T., Petri, M., Furie, R. A., Morgan-Cox, M. A., Taha, R., Watts, S., Silk, M. & Linnik, M. D. Jan 1 2018 In : Rheumatology (Oxford, England). 57, 1, p. 125-133 9 p.

Research output: Contribution to journalArticle

Systemic Lupus Erythematosus
Medication Adherence
Clinical Trials
Adrenal Cortex Hormones
Alopecia

Complement activation predicts adverse pregnancy outcome in patients with systemic lupus erythematosus and/or antiphospholipid antibodies

Kim, M. Y., Guerra, M. M., Kaplowitz, E., Laskin, C. A., Petri, M., Branch, D. W., Lockshin, M. D., Sammaritano, L. R., Merrill, J. T., Porter, T. F., Sawitzke, A., Lynch, A. M., Buyon, J. P. & Salmon, J. E. Apr 1 2018 In : Annals of the rheumatic diseases. 77, 4, p. 549-555 7 p.

Research output: Contribution to journalArticle

Antiphospholipid Antibodies
Complement Activation
Pregnancy Outcome
Systemic Lupus Erythematosus
Chemical activation